BECHINI, ANGELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.250
EU - Europa 11.200
AS - Asia 3.531
SA - Sud America 302
OC - Oceania 198
AF - Africa 82
Continente sconosciuto - Info sul continente non disponibili 2
Totale 26.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.203
PL - Polonia 3.232
RU - Federazione Russa 3.136
IT - Italia 1.842
HK - Hong Kong 1.055
SG - Singapore 922
IE - Irlanda 861
SE - Svezia 736
CN - Cina 426
DE - Germania 287
BR - Brasile 255
IN - India 236
FI - Finlandia 218
AU - Australia 193
GB - Regno Unito 177
JO - Giordania 177
CH - Svizzera 165
TR - Turchia 152
KR - Corea 148
FR - Francia 138
ID - Indonesia 107
UA - Ucraina 106
NL - Olanda 80
VN - Vietnam 71
CI - Costa d'Avorio 45
ES - Italia 44
TH - Thailandia 43
IR - Iran 39
PH - Filippine 31
BE - Belgio 23
CA - Canada 21
CZ - Repubblica Ceca 21
GR - Grecia 18
PE - Perù 17
TW - Taiwan 17
AR - Argentina 15
PT - Portogallo 14
HR - Croazia 12
LV - Lettonia 12
MX - Messico 12
MY - Malesia 12
AT - Austria 11
BG - Bulgaria 11
JP - Giappone 11
SI - Slovenia 10
RO - Romania 9
SA - Arabia Saudita 9
ZA - Sudafrica 9
AE - Emirati Arabi Uniti 8
KZ - Kazakistan 7
LT - Lituania 7
EG - Egitto 6
HU - Ungheria 6
PK - Pakistan 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
BH - Bahrain 5
EC - Ecuador 5
AL - Albania 4
AM - Armenia 4
BD - Bangladesh 4
CO - Colombia 4
CY - Cipro 4
IL - Israele 4
KE - Kenya 4
MA - Marocco 4
NO - Norvegia 4
NP - Nepal 4
SC - Seychelles 4
FJ - Figi 3
NG - Nigeria 3
PA - Panama 3
QA - Qatar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TT - Trinidad e Tobago 3
CL - Cile 2
CM - Camerun 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
IQ - Iraq 2
IS - Islanda 2
JM - Giamaica 2
KG - Kirghizistan 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
SM - San Marino 2
TJ - Tagikistan 2
TN - Tunisia 2
AN - Antille olandesi 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 26.555
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.703
Warsaw 3.216
Fairfield 862
Hong Kong 861
Dublin 854
Chandler 724
Singapore 537
Ashburn 474
Cambridge 371
Seattle 358
Woodbridge 350
Florence 310
Houston 302
Wilmington 281
Princeton 239
Lawrence 210
Altamura 207
Mumbai 191
Jacksonville 180
Beijing 176
Boston 175
Buffalo 173
Ann Arbor 153
Bern 151
Boardman 143
Moscow 135
Melbourne 132
New York 98
Medford 95
Shanghai 95
Jakarta 93
Rome 92
Paris 77
San Diego 75
Izmir 71
Kent 69
Milan 68
Los Angeles 67
Helsinki 64
Dong Ket 56
Abidjan 45
Sydney 45
Bremen 41
Norwalk 41
London 39
Dearborn 36
Bangkok 31
Falkenstein 28
Hillsboro 28
Munich 28
Naples 24
Falls Church 23
Andover 21
Genoa 21
Yubileyny 21
Barcelona 20
Seodaemun-gu 20
Phoenix 18
Seoul 18
São Paulo 18
Bari 17
Seo-gu 17
Toronto 17
Brussels 16
Padova 16
Amsterdam 15
Bologna 15
Gangnam-gu 15
Lima 15
Catania 14
Palermo 14
Pisa 14
Plymouth 14
Roelofarendsveen 14
West Jordan 14
Pune 13
Redwood City 13
Cagliari 12
Frankfurt am Main 12
Goyang-si 12
Riga 12
Rio de Janeiro 12
Ancona 11
Guangzhou 11
Philadelphia 11
Brno 10
Rimini 10
Turin 10
Auburn Hills 9
Bergamo 9
Hamburg 9
Lucca 9
Manchester 9
Napoli 9
Perugia 9
Prato 9
Riyadh 9
The Dalles 9
Verona 9
Ankara 8
Totale 17.537
Salva come PNG Salva come JPEG
Nome #
Measuring health literacy in Italy: A validation study of the HLS-EU-Q16 and of the HLS-EU-Q6 in Italian language, conducted in Florence and its surroundings 1.041
Vaccinazioni e asplenia: quale percorso per il paziente splenectomizzato? 457
HPV vaccination for boys? A systematic review of economic studies 332
Antimeningococcal and antipneumococcal vaccination determinants: A European systematic literature review 306
Assessment of humoral and cell-mediated immunity against Bordetella pertussis in adolescent, adult, and senior subjects in Italy 283
Determinants of European parents' decision on the vaccination of their children against measles, mumps and rubella: A systematic review and meta-analysis 263
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 258
Primary hepatitis A vaccination failure is a rare although possible event: results of a retrospective study 252
Human papilloma virus vaccination: impact and recommendations across the world. 250
Development and preliminary data on the use of a mobile app specifically designed to increase community awareness of invasive pneumococcal disease and its prevention 246
Health literacy in Italy: a cross-sectional study protocol to assess the health literacy level in a population-based sample, and to validate health literacy measures in the Italian language 245
Preparing to introduce the varicella vaccine into the Italian immunisation programme: Varicella-related hospitalisations in Tuscany, 2004-2012 242
Pneumococcal serotype distribution in adults with invasive disease and in carrier children in Italy: Should we expect herd protection of adults through infants’ vaccination? 234
Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012 231
The epidemiology of mumps in Italy 231
The epidemiology of Varicella Zoster Virus infection in Italy. 225
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 214
Is Italian population protected from Poliovirus? Results of a seroprevalence survey in Florence, Italy 212
The role of the general practitioner in the screening and clinical management of chronic viral hepatitis in six EU countries. 211
How can the results of Health Technology Assessment (HTA) evaluations applied to vaccinations be communicated to decision-makers and stakeholders? The ISPOR Rome chapter project 208
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 193
Non-familial paid caregivers as potential flu carriers and cause of spread: the primary prevention of flu measured through their adhesion to flu vaccination campaigns—A Florentine experience 193
Adjuvanted influenza vaccine for the Italian elderly in the 2018/19 season: an updated health technology assessment 192
Impact of universal vaccination against varicella in Italy: Experiences from eight Italian Regions 191
Raccomandazioni ed evidenze scientifiche a supporto del valore della vaccinazione DTPa-IPV in età prescolare 181
Identification of hepatitis B and C screening and patient management guidelines and availability of training for chronic viral hepatitis among health professionals in six European countries: Results of a semi-quantitative survey 175
Do Tuscan people adhere to meningococcal C vaccination during an emergency campaign? 172
Impact of vaccination programs against measles, varicella and meningococcus C in Italy and in Tuscany and public health policies in the last decades 167
Estimating the scale of chronic hepatitis B virus infection among migrants in EU/EEA countries 166
Safety and perception: What are the greatest enemies of HPV vaccination programmes? 159
Recrudescenza di casi di malattia meningococcica invasiva in Toscana e strategie vaccinali adottate dal 2015 158
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 157
Economic and clinical evaluation of a catch-up dose of 13-valent pneumococcal conjugate vaccine in children already immunized with three doses of the 7-valent vaccine in Italy 153
Health literacy as a mediator of the relationship between socioeconomic status and health: A cross-sectional study in a population-based sample in Florence 149
Childhood Vaccination Coverage in Europe: Impact of different Public Health Policies 148
Progress in Italy in control and elimination of measles and congenital rubella. 148
L’EFFICACIA DEL PROGRAMMA DI VACCINAZIONE UNIVERSALE ANTI-VARICELLA IN TOSCANA: EVIDENZE DI UN OBIETTIVO RAGGIUNGIBILE DEL PNPV. 147
Recommended vaccinations for asplenic and hyposplenic adult patients 145
INCREASING RESISTANCE IN COMMENSAL ESCHERICHIA COLI, BOLIVIA AND PERU 141
Progress in Italy in control and elimination of measles and congenital rubella. 141
Evaluation of bivalent human papillomavirus (HPV) vaccine safety and tolerability in a sample of 25 year old Tuscan women. 141
Referral of newly diagnosed chronic hepatitis B and C patients in six EU countries: Results of the HEPscreen Project 136
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy. 135
Health literacy and vaccination: A systematic review 132
Attitude toward immunization and risk perception of measles, rubella, mumps, varicella, and pertussis in health care workers working in 6 hospitals of Florence, Italy 2011. 131
Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy 130
Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination. 123
The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment 123
Rubella seroprevalence boost in the pediatric and adolescent population of florence (Italy) as a preventive strategy for congenital rubella syndrome (CRS) 123
Human papillomavirus prevalence in paired urine and cervical samples in women invited for cervical cancer screening 123
The appropriateness of the use of influenza vaccines: Recommendations from the latest seasons in Italy 123
Cost-effectiveness of new adult pneumococcal vaccination strategies in Italy. 119
Strategies and actions of multi-purpose health communication on vaccine preventable infectious diseases in order to increase vaccination coverage in the population: The ESCULAPIO project 119
Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): A review of evidences and recommendations 118
SARS-CoV-2 Seroprevalence Survey in People Involved in Different Essential Activities during the General Lock-Down Phase in the Province of Prato (Tuscany, Italy) 117
Epidemiologia storica della rosolia in Toscana e nuovo flusso di notifica obbligatoria 115
Valutazione dell’immunità umorale e cellulo-mediata verso Bordetella pertussis in Toscana 115
An overview on the implementation of HPV vaccination in Europe. 114
Focusing on the implementation of 21st century vaccines for adults 114
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy. 112
Utility of healthcare system-based interventions in improving the uptake of influenza vaccination in healthcare workers at long-term care facilities: A systematic review. 112
Gli operatori sanitari degli ospedali fiorentini: protetti o non protetti verso morbillo, parotite, rosolia e varicella? 112
Impact of influenza vaccination on all-cause mortality and hospitalization for pneumonia in adults and the elderly with diabetes: A meta-analysis of observational studies 111
Analisi delle reazioni avverse alla prima dose di vaccini antimorbillo e antivaricella in Toscana dal 2011-2014. 110
Efficacy, duration of immunity and cross protection after HPV vaccination: A review of the evidence 109
La sorveglianza di laboratorio dei casi di sospetto morbillo in Toscana dal 2004 al 2012. 109
Evaluating the costs and benefits of pneumococcal vaccination in adults 108
Key points for the decision maker 108
Analisi costo-efficacia della vaccinazione anti-meningococcica con vaccino coniugato quadrivalente ACYW135 in Italia. 107
Eliminazione del morbillo: risultati e prospettive nella Regione Toscana 106
Valutazione del rischio di morbillo, rosolia e parotite negli operatori sanitari dell’azienda sanitaria di Firenze (ASF) 106
Epatite B e C: pratiche di counselling e referral in soggetti migranti (progetto HEPSCREEN) 106
High chance to overcome the non-responder status to hepatitis B vaccine after a further full vaccination course: results from the extended study on healthcare students and workers in Florence, Italy 106
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 105
Awareness of hepatitis B and C screening and patient management guidelines among health professionals in six European countries 105
Perspectives of public health: present and foreseen impact of vaccination on the epidemiology of hepatitis B 105
Travelers' compliance to prophylactic measures and behavior during stay abroad: results of a retrospective study of subjects returning to a travel medicine center in Italy. 105
The role of health literacy in covid-19 preventive behaviors and infection risk perception: Evidence from a population-based sample of essential frontline workers during the lockdown in the province of prato (tuscany, italy) 105
The expected impact of new vaccines and vaccination policies. 104
The burden of disease of Herpes Zoster in Tuscany 104
Measurement and reporting of burden of disease for hepatitis a: results of the EUROHEP.NET feasibility survey 103
Implementation of the Plan for Elimination of Measles and Congenital Rubella Infection in Tuscany: evidence of progress towards phase II of measles control 103
Le abitudini sessuali e i fattori di rischio per l'infezione da HPV degli studenti di Infermieristica dell'Università di Firenze: uno studio pilota 103
Assessment of the clinical and economic impact of different immunization protocols of measles, mumps, rubella and varicella in internationally adopted children 103
Discrepancies between vaccine documentation and serologic status for diphtheria, tetanus, and hepatitis b in internationally adopted children 103
Application of socio-economic-health deprivation index, analysis of mortality and influenza vaccination coverage in the elderly population of Tuscany 103
Donne in gravidanza e vaccinazioni: impatto di un intervento educativo nel territorio fiorentino 102
Hepatitis B seroprevalence in the pediatric and adolescent population of florence (Italy): An update 27 years after the implementation of universal vaccination 102
Le abitudini sessuali e i fattori di rischio per l’infezione da HPV degli studenti toscani. 102
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 102
20 anni di vaccinazione anti-epatite B in Italia: una valutazione economica. 101
Un caso di studio su una sospetta associazione tra vaccinazione anti-varicella e reazione avversa a vaccino. 101
Valutazione dell’efficacia del programma di vaccinazione antivaricella in Toscana, nella ASL di Firenze e nella ASL di Prato nel periodo 2009-2013. 100
Hospitalizations for pneumonia, invasive diseases and otitis in Tuscany (Italy), 2002-2014 100
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) 100
The experience of vaccinarsintoscana website and the role of new media in promoting vaccination 99
A cost-benefit analysis of different varicella vaccination strategies involving italian children and adolescents. 99
Factors influencing sars-cov-2 vaccine acceptance and hesitancy in a population-based sample in Italy 99
Electronic Package Leaflets for Vaccines: What Are People's Perceptions in Italy? 98
Clinical and economic impact of herpes zoster vaccination in elderly in Italy 98
Totale 15.844
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.357
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020605 0 0 0 0 0 0 0 0 0 270 280 55
2020/20211.932 158 195 80 201 110 234 96 148 176 308 77 149
2021/20221.452 55 180 82 54 38 38 47 128 40 59 270 461
2022/20234.050 344 616 219 259 250 706 543 235 529 28 134 187
2023/20242.545 88 201 296 177 227 292 195 340 109 228 222 170
2024/202511.054 467 1.277 796 1.816 3.319 1.625 243 648 534 329 0 0
Totale 26.830